Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment
- Pepin M.
- Ferreira A. C.
- Arici M.
- Bachman M.
- Barbieri M.
- Bumblyte I. A.
- Carriazo S.
- Delgado P.
- Garneata L.
- Giannakou K.
- Godefroy O.
- Grodzicki T.
- Klimkowicz-Mrowiec A.
- Kurganaite J.
- Liabeuf S.
- Mocanu C. A.
- Paolisso G.
- Spasovski G.
- Vazelov E. S.
- Viggiano D.
- Zoccali C.
- Massy Z. A.
- Wiecek A.
DOIAbstract
Neurocognitive disorders are frequent among chronic kidney disease (CKD) patients. Identifying and characterizing cognitive impairment (CI) can help to assess the ability of adherence to CKD risk reduction strategy, identify potentially reversible causes of cognitive decline, modify pharmacotherapy, educate the patient and caregiver and provide appropriate patient and caregiver support. Numerous factors are associated with the development and progression of CI in CKD patients and various conditions can influence the results of cognitive assessment in these patients. Here we review clinical warning signs that should lead to cognitive screening; conditions frequent in CKD at risk to interfere with cognitive testing or performance, including s...
Add to ORKG